Role of TBX1 in human del22q11.2 syndrome

Lancet

Volumn 362, Issue 9393, 2003, Pages 1366-1373

  Yagi, Hisato ^a   Furutani, Yoshiyuki ^a   Hamada, Hiromichi ^b   Sasaki, Takashi ^c   Asakawa, Shuichi ^c   Minoshima, Shinsei ^c   Ichida, Fukiko ^d   Joo, Kunitaka ^e   Kimura, Misa ^a   Imamura, Shin ichiro ^a   Kamatani, Naoyuki ^a   Momma, Kazuo ^a   Takao, Atsuyoshi ^a   Nakazawa, Makoto ^a   Shimizu, Nobuyoshi ^c   Matsuoka, Rumiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

^e Kyushu Welfare Pension Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 22Q; CHROMOSOME DELETION; CHROMOSOME DISORDER; CLEFT PALATE; CONTROLLED STUDY; DEL22Q11 2 SYNDROME; DIGEORGE SYNDROME; FEMALE; GENE DELETION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; HUMAN; HYPOCALCEMIA; IN SITU HYBRIDIZATION; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; VELOCARDIOFACIAL SYNDROME;

EID: 10744223651     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14632-6     Document Type: Article

References (30)

1. Burn J., Wilson D.I., Cross I., et al. The clinical significance of 22q11 deletion. Clark E.B., Markwald R.R., Takao A. Developmental mechanisms of heart disease. 1995;559-567 Futura, New York.
2. DiGeorge A.M. Discussion on a new concept of the cellular basis of immunity. J Pediatr. 67:1965;907-908.
3. Kinouchi A., Mori K., Ando M., Takao A. Facial appearance of patients with conotruncal anomalies. Pediatr Jpn. 17:1976;84.
4. Takao A., Ando M., Cho K., Kinouchi A., Murakami Y. Etiologic categorization of common congenital heart disease. Van Praagh R., Takao A. Etiology and morphogenesis of congenital heart disease. 1980;253-269 Futura, New York.
5. Shprintzen R.J., Goldberg R.B., Lewin M.L., et al. A new syndrome involving cleft palate, cardiac anomalies, typical facies and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J. 15:1978;56-62.
6. Scambler P.J. The 22q11 deletion syndromes. Hum Mol Genet. 9:2000;2421-2426.
7. Lindsay E.A. Chromosomal microdeletions: dissectiog del 22q11 syndrome. Nat Rev Genet. 2:2001;858-868.
8. Yamagishi H. The 22q11.2 deletion syndrome. Keio J Med. 51:2002;77-88.
9. Lindsay E.A., Vitelli F., Su H., et al. Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature. 410:2001;97-101.
10. Jerome L.A., Papaioannou V.E. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet. 27:2001;286-291.
11. Merscher S., Funke B., Epstein J.B., et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell. 104:2001;619-629.
12. Gong W., Gottelieb S., Collins, et al. Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects. J Med Genet. 38:2001;e45.
13. Conti E., Grifone N., Sarkozy A., et al. DiGeorge subtypes of nonsyndromic conotruncal defects: evidence against a major role of TBX1 Gene. Eur J Hum Genet. 11:2003;349-351.
14. Yoshida M.C., Satoh H., Sasaki M., et al. Regional location of a novel yes-related protooncogene, syn, on human chromosome 6 at band q21. Jpn J Cancer Res. 77:1986;1059-1061.
15. Matsuoka R., Kimura M., Scambler P.J., et al. Molecular and clinical study of 183 patients with conotruncal anomaly face syndrome. Hum Genet. 103:1998;70-80.
16. Asakawa S., Abe I., Kudoh Y., et al. Human BAC library: construction and rapid screening. Gene. 191:1997;69-79.
17. Matsuoka R., Furutani M., Kimura M., et al. Genotype-phenotype correlations in del 22q11.2 syndrome. Clark E.B., Nakazawa M., Takao A. Etiology and morphogenesis of congenital heart disease. 2000;341-346 Futura, New York.
18. Yamagishi H., Ishii C., Maeda J., et al. Phenotypic discordance in monozygotic twins with 22q11.2 deletion. Am J Med Genet. 78:1998;319-321.
19. MacQuade L., Christodoulou J., Budarf M., et al. Patient with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR). Am J Med Genet. 86:1999;27-33.
20. Paxton C., Zhao H., Chin Y., Langner K., Reecy J. Murine Tbx2 contains domains that activate and repress gene transcription. Gene. 283:2002;117-124.
21. Papaioannou V.E., Silver L.M. The T-box gene family. BioEssays. 20:1998;9-19.
22. Wilkinson D.G., Bhatt S., Herrmann B.G. Expression pattern of the mouse T gene and its role in mesoderm formation. Nature. 343:1990;657-659.
23. Peckam E.A., Brook J.D. T-box genes in human disorders. Hum Mol Genet. 12:(suppl):2003;R37-R44.
24. Tada M., Smith J.C. T-targets: clues to understanding the functions of T-box proteins. Dev Growth Differ. 43:2001;1-11.
25. Frank D.U., Fotheringham L.K., Brewer J.A., et al. An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome. Development. 129:2002;4591-4603.
26. Vitelli F., Taddei I., Morishima M., et al. A genetic link between Tbx1 and fibroblast growth factor signaling. Development. 129:2002;4605-4611.
27. Abu-Issa R., Smyth G., Smock I., Yamamura K., Meyers E.N. Fgf8 is required for pharingeal arch and cardiovascular development. Development. 129:2002;4613-4625.
28. Yamagishi H., Maeda J., Hu T., et al. Tbx1 is regulated by tissue-specific forkhead proteins through a common Sonic hedgehog-responsive enhancer. Genes Dev. 17:2003;269-281.
29. Matsuoka R., Takao A., Kimura M., et al. Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within chromosome 22q11. Am J Med Genet. 53:1994;285-289.
30. Shprintzen R.J. Velocardiofacial syndrome and DiGeorge sequence. Med Genet. 31:1994;423-424.